about
The three transfer RNAs occupying the A, P and E sites on the ribosome are involved in viral programmed -1 ribosomal frameshiftTranslation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyproteinSelection of peptides interfering with a ribosomal frameshift in the human immunodeficiency virus type 1A functional relationship between helix 1 and the 900 tetraloop of 16S ribosomal RNA within the bacterial ribosome.Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1.The activity of the HIV-1 IRES is stimulated by oxidative stress and controlled by a negative regulatory elementReplacement of murine leukemia virus readthrough mechanism by human immunodeficiency virus frameshift allows synthesis of viral proteins and virus replication.Targeting frameshifting in the human immunodeficiency virus.The presence of the TAR RNA structure alters the programmed -1 ribosomal frameshift efficiency of the human immunodeficiency virus type 1 (HIV-1) by modifying the rate of translation initiation.The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M.A reassessment of the response of the bacterial ribosome to the frameshift stimulatory signal of the human immunodeficiency virus type 1.Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates.Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1.The frameshift stimulatory signal of human immunodeficiency virus type 1 group O is a pseudoknot.
P50
Q24565015-F7626AB6-E4A4-4FDE-AF64-EBFE39B26E9DQ24795677-7BE28F04-EA19-4B3D-84D9-D522D461EB54Q33325834-8E8F9082-7CA4-4349-A3D3-1571862EFC34Q34366432-8D314C40-AEBF-42CC-AFDA-2B53EC232C07Q34396936-F746FAAA-07A9-4B6D-A5ED-BB26D3FDA56EQ34559697-98AD73A9-195E-4696-8E6C-57B11AAA43C0Q34757472-350231E3-EA3E-421D-948D-2D88EDD526BAQ37992096-E882D0E7-BF8B-4F5D-BA7C-C1DB3B8C6690Q40056035-53BA1ECD-3AC8-451C-93E9-44C66C54DC1AQ40444598-5EB76B16-174E-46DD-87F4-6D80FF6EFE70Q41510614-2E291A41-1FC9-43F9-9294-7D663AACF1BDQ41848089-6B8DDB3D-B88B-4F78-9806-1E7E146518B0Q42116136-8CAB9D6C-469B-40E2-B74B-165C54648AD5Q44421216-B1EE4C94-9E5D-4E26-8180-71271EEA21DAQ45422942-1C3307E4-8ECA-479A-A4FF-D645EA5BCE93Q45722357-6CE0D51D-B743-46D7-92E3-6C1B3D9BE834
P50
name
Léa Brakier-Gingras
@ast
Léa Brakier-Gingras
@en
Léa Brakier-Gingras
@fr
Léa Brakier-Gingras
@nl
type
label
Léa Brakier-Gingras
@ast
Léa Brakier-Gingras
@en
Léa Brakier-Gingras
@fr
Léa Brakier-Gingras
@nl
prefLabel
Léa Brakier-Gingras
@ast
Léa Brakier-Gingras
@en
Léa Brakier-Gingras
@fr
Léa Brakier-Gingras
@nl